Inhibition of Drp1 using a selective Drp1 peptide inhibitor for treatment of alpha-synuclein associated Parkinson’s Disease. Awarded $100,000 over 2 years.

Single Cell Characterization of Epigenetic Mechanisms Underlying Cocaine Craving. Awarded $100,000 over 2 years.

Examining and identifying function and role of LPHN3 in ADHD. Awarded $100,000 over 2 years.

Identifying the genetic risk underlying poor cognitive recovery after traumatic brain injury. Awarded $100,000 over 2 years.

Developing a neuron replacement therapy to improve breathing, motor function and survival in neurodegenerative disease. Awarded $100,000 over 2 years.

Exploring the role of the oncogene Dek as a novel player in Alzheimer's disease. Awarded $100,000 over 2 years.

Non-invasive IPSC-based Therapies for Treatment of Neurodegenerative Diseases. Awarded $100,000 over 2 years.

Proteomic and genomic investigation of PSD-95 protein-protein interactions in schizophrenia. Awarded $100,000 over 2 years.